iRadimed (IRMD)
(Delayed Data from NSDQ)
$44.40 USD
-1.75 (-3.79%)
Updated Aug 2, 2024 04:00 PM ET
After-Market: $44.26 -0.14 (-0.32%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth B Momentum C VGM
Price, Consensus and EPS Surprise
IRMD 44.40 -1.75(-3.79%)
Will IRMD be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for IRMD based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for IRMD
IRadimed (IRMD) Surpasses Q2 Earnings and Revenue Estimates
Acadia Healthcare (ACHC) Opens Facility to Serve California
IRMD: What are Zacks experts saying now?
Zacks Private Portfolio Services
UnitedHealth (UNH) Unit Awarded a Medicaid Contract by AHCCCS
Centene's (CNC) Ambetter Enhances Offerings With Broward Health
Centene (CNC) Wins Contract From Arizona's Medicaid Agency
Other News for IRMD
IRADIMED CORPORATION (IRMD) Q2 2024 Earnings Call Transcript
iRadimed price target lowered by $5 at Roth MKM, here's why
Iradimed (IRMD) Gets a Buy from Roth MKM
IRADIMED CORPORATION Announces Second Quarter of 2024 Financial Results and the Declaration of its Regular Quarterly Cash Dividend of $0.15 Per Share
iRadimed Non-GAAP EPS of $0.42 beats by $0.06, revenue of $17.93M beats by $0.28M